Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 18, 2003

View Archived Issues

Improved MRA imaging with MS-325 in the detection of AIOD

Potential applications of ferumoxytol discussed at RSNA 2003

Adherex to acquire noncancer assets from Cadherin Biomedical

ZymoGenetics advances product candidates into clinic in 2003

Phase I study evaluates Aastrom dendritic cell-based vaccine for GI cancers

Bionomics and Brigham & Women's collaborate to identify epilepsy genes

CytoGenix ssDNA technology to be evaluated against bacterial sepsis

Orphan drug designation for DX-890 for cystic fibrosis

Pariet submitted for ZES and pathological hypersecretory conditions in Europe

GMP Companies collaborates with U. of Michigan on benzodiazepine technology

Phase I trial of topotecan TCS delayed until Q3 2004

New agreement to develop PLD-177 with Clickhaler technology

New PDE5 inhibitors reported by SK Chemicals and In2Gen team

Another series of GABA-A receptor modulators identified by Neurogen researchers

Novel 5-HT4 agonist with good safety profile and its use in GI motility disorders

Inhibitors of IL-12 production prepared and tested at Taisho

Schering AG patent covers new iNOS inhibitors and their use

CC-5013 safe and effective in hematological malignancies

Clioquinol slows rate of cognitive decline in Alzheimer's disease

Antitumor effects of CCI-779 in multiple myeloma and MCL

Efficacy and safety of lonafarnib in hematological tumors

Cytopia and Myomatrix collaborate in cardiovascular disease

COMBAT study to assess dutasteride plus tamsulosin for BPH

GTC takes equity position in Merrimack under amended MM-093 agreement

SomatoKine granted orphan drug designation for extreme insulin resistance

Investigators meeting precedes phase III Xerecept program

Xenical approved for obese adolescents

Sosei and Nippon Organon to copromote SOT-375 in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...